Clinical Trial Update: Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients [NA]

View source ↗

Summary

This clinical trial update describes a study on molecular mechanisms of relapse after allogeneic stem cell transplantation in myelodysplastic Syndromes. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Myelodysplastic Syndromes | NA | Status: RECRUITING